Electromedical's
Flagship WellnessPro Plus Technology on Exhibit This Week at
PAINWeek 2022 in Las Vegas from Sep 6-9
Scottsdale, AZ.
-- September 8, 2022 -- InvestorsHub NewsWire --
Electromedical Technologies, Inc. (OTCQB:
EMED) ("Electromedical" or the "Company"), a pioneer in the
development and production of bioelectronic devices designed to
relieve chronic, intractable, and acute pain by using frequencies
and electro-modulation, is excited to announce that the Company is
exhibiting its flagship product, the WellnessPro Plus, at the world
renowned
PAINWeek national
conference event (www.painweek.org)
this week from September 6 thru September 9 at the Cosmopolitan
Hotel in the heart of the Las Vegas strip.
PAINWeek 2021 was the
largest pain conference in the United States, drawing over 1,500
attendees in the pain management field.
Representatives from the
Company will be on hand at Booth #205 at the facility's new
"Experience Zone". Interested attendees are invited to visit the
Electromedical booth and try the WellnessPro Plus firsthand to
experience the magic of drug-free pain relief.
"PAINWeek offers us the
perfect venue to demonstrate the power and efficacy of our core
technology," remarked Matthew Wolfson, Founder and CEO of
Electromedical. "We will have access to an exceptionally well
targeted crowd, including physicians, physician assistants, nurse
practitioners, nurses, pharmacists, hospitalists, physical
therapists, psychologists, and other pain management
professionals."
The event will also
serve as a platform for the Company to begin to generate buzz ahead
of the completion of its new Gen-3 WellnessPro Plus next-generation
prototype, which is expected to be completed this
month.
PAINWeek has been a leading
resource for frontline practitioners treating acute and chronic
pain for over 15 years. The annual PAINWeek conference presents
over 75 hours of accredited continuing medical education, composed
of multidisciplinary course concentrations, master classes, special
interest sessions, and satellite events geared toward healthcare
professionals in the pain management industry.
About
Electromedical Technologies
Headquartered in Scottsdale,
Arizona, Electromedical Technologies, Inc. is a commercial stage,
FDA cleared, bioelectronic medical device manufacturing company
initially focused on the treatment of various chronic, acute,
intractable, and post-operative pain conditions. Through University
collaboration agreements, the Company is working to develop a
comprehensive research program in defining the effects of
electro-modulation on the human body. By studying the impacts of
electrical fields in cell signaling and effects on virus assembly
and immune responses, the Company's goal is to reduce pain and
improve overall human wellbeing. The Company's current FDA cleared
product indications are for chronic acute post traumatic and
post-operative, intractable pain relief.
For more information, please
visit
www.electromedtech.com.
Note: Nonhuman preliminary
studies that we are planning to start in the near future and their
applications are not related to our current product in any way and
are currently not cleared in the US.
Safe
Harbor Statement
This
release contains forward-looking statements that are based upon
current expectations or beliefs, as well as a number of assumptions
about future events. Although we believe that the expectations
reflected in the forward-looking statements and the assumptions
upon which they are based are reasonable, we can give no assurance
or guarantee that such expectations and assumptions will prove to
have been correct. Forward-looking statements are generally
identifiable by the use of words like "may," "will," "should,"
"could," "expect," "anticipate," "estimate," "believe," "intend,"
or "project" or the negative of these words or other variations on
these words or comparable terminology. The reader is cautioned not
to put undue reliance on these forward-looking statements, as these
statements are subject to numerous factors and uncertainties,
including but not limited to: adverse economic conditions,
competition, adverse federal, state and local government
regulation, international governmental regulation, inadequate
capital, inability to carry out research, development and
commercialization plans, loss or retirement of key executives and
other specific risks. To the extent that statements in this press
release are not strictly historical, including statements as to
revenue projections, business strategy, outlook, objectives, future
milestones, plans, intentions, goals, future financial conditions,
events conditioned on stockholder or other approval, or otherwise
as to future events, such statements are forward-looking, and are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. The forward-looking
statements contained in this release are subject to certain risks
and uncertainties that could cause actual results to differ
materially from the statements made.
Corporate
Contact:
Electromedical Technologies,
Inc.
Tel:
1.888.880.7888
Email:
ir@electromedtech.com
https://electromedtech.com